In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain
- 1 May 1995
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 351 (5) , 475-482
- https://doi.org/10.1007/bf00171038
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Plasma 5‐Hydroxyindoleacetic Acid as an Indicator of Monoamine Oxidase‐A Inhibition in Rat Brain and Peripheral TissuesJournal of Neurochemistry, 1993
- Monoamine oxidase inhibitors in resistant major depression: A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressantsJournal of Affective Disorders, 1993
- 5-HT and antidepressants: new views from microdialysis studiesTrends in Pharmacological Sciences, 1993
- Brofaromine - a Selective, Reversible, and Short-Acting MAO-A Inhibitor: Review of the Pharmacological and Clinical FindingsPharmacopsychiatry, 1991
- Serotonin Metabolism by Monoamine Oxidase in Rat Primary Astrocyte CulturesJournal of Neurochemistry, 1990
- Histochemical localisation of monoamine oxidase A and B in rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat BrainJournal of Neurochemistry, 1986
- An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of mao A and BPharmacology & Therapeutics, 1985
- Distinct Monoamine Oxidase A and B Populations in Primate BrainScience, 1985
- High-Affinity Uptake of Serotonin Into Immunocytochemically Identified AstrocytesScience, 1985